"We desire Essar to be with the venture as our local partner. But if they decide to exit, we are offering the same price as we made for HTIL's stake," Sarin said.
Sources in the know said that HTIL's offer inviting bids had made it clear that the company had the final say in accepting or rejecting a bid, even if of a higher value. A HTIL spokesperson could not be contacted for comments.
Before the bidding process, Essar had asserted its Right of First Refusal, which Sarin said was not valid vis-à-vis Vodafone.
Asked about the exact investment that Vodafone would be making in Hutch-Essar, including acquisition of 52 per cent stake, Sarin said, "It will be in double digit (meaning $10 billion or more).
While Vodafone got control of 67 per cent equity for $11.1 billion, the UK company has not actually bought 15 per cent stake bing held by minority shareholders including Max
Health Care chief Analjit Singh and Hutch-Essar managing director Asim Ghosh, being favoured by Sarin to continue in his present position.
Consequently, Vodafone's 52 per cent equity would be valued at just below $9 billion, while Sarin has promised to pump in another two $2 billion for expansion of the venture, which he feels would be the biggest in the group in terms of number of subscribers.
The race for Hutch-Essar: Complete coverage